Showing results (271-280 of 286) with videos related to
Sort By:
Pageof 29
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.Cancer Discovery|October 11, 2011
Temporal dissection of tumorigenesis in primary cancersSteffen Durinck, Christine Ho, Nicholas J Wang, et al.Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Diverse Genomes, Shared Health: Insights from a Health System BiobankRoni Haas, Michael P Margolis, Angela Wei, et al.Proceedings of the National Academy of Sciences of the United States of America|October 19, 2011
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinomaNicholas J Wang, Zachary Sanborn, Kelly L Arnett, et al.Cell|March 28, 2026
Advancing precision health discovery in a genetically diverse health systemRoni Haas, Michael P Margolis, Angela Wei, et al.Nature Medicine|May 5, 2015
Functionally defined therapeutic targets in diffuse intrinsic pontine gliomaCatherine S Grasso, Yujie Tang, Nathalene Truffaux, et al.The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.Nature Methods|February 23, 2016
Inferring causal molecular networks: empirical assessment through a community-based effortSteven M Hill, Laura M Heiser, Thomas Cokelaer, et al.Nature|February 7, 2020
The evolutionary history of 2,658 cancersMoritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.Pageof 29